Canadian older adults' perceptions of effectiveness and value of regular and high-dose influenza vaccines
- PMID: 30204043
- PMCID: PMC6422457
- DOI: 10.1080/21645515.2018.1520580
Canadian older adults' perceptions of effectiveness and value of regular and high-dose influenza vaccines
Abstract
Influenza vaccination is an important public health intervention for older adults, yet vaccination rates remain suboptimal. We conducted an online survey of Canadians ≥ 65 years to explore satisfaction with publicly-funded standard-dose influenza vaccines, and perceptions of the need for a more effective product. They were provided with information about currently approved influenza vaccines, and were asked about their preferences should all formulations be available for free, and should the recently approved high-dose (HD) vaccine for seniors be available at a cost. From March to April 2017, 5014 seniors completed the survey; mean age was 71.3 ± 5.17 years, 50% were female, and 42.6% had one or more chronic conditions. 3403 (67.9%) had been vaccinated against influenza in the 2016/17 season. Of all respondents, 3460 (69%) were satisfied with the standard-dose influenza vaccines, yet 3067 (61.1%) thought that a more effective vaccine was/may be needed. If HD was only available at a cost, 1426 (28.4%) respondents would consider it, of whom 62.9% would pay $20 or less. If all vaccines were free next season, 1914 (38.2%) would opt for HD (including 12.2% of those who previously rejected influenza vaccines), 856 (17.1%) would choose adjuvanted vaccine, and 558 (11.1%) standard-dose vaccine. 843 (16.8%) of respondents were against vaccines, 451 (9.0%) had no preference and 392 (7.8%) were uncertain. Making this product available through publicly funded programs may be a strategy to increase immunization rates in this population.
Keywords: Influenza; Survey; Vaccines; decision-making; seniors; willingness-to-pay.
Figures
References
-
- Kwong JC, Ratnasingham S, Campitelli MA, Daneman N, Deeks SL, Manuel DG, Allen VG, Bayoumi AM, Fazil A, Fisman DN, et al. The impact of infection on population health: Results of the Ontario Burden of Infectious Diseases Study. PLoS ONE. 2012;7(9):e44103. doi: 10.1371/journal.pone.0044103. - DOI - PMC - PubMed
-
- Nichols KL. Influenza vaccination in the elderly: impact on hospitalization and mortality. Drugs Aging. 2005;22(6):495–515. - PubMed
-
- Covinsky KE, Palmer RM, Fortinsky RH, Counsell SR, Stewart AL, Kresevic D, Burant CJ, Landefeld CS. Loss of independence in activities of daily living in older adults hospitalized with medical illnesses: increased vulnerability with age. J Am Geriatr Soc. 2003. April;51(4):451–458. - PubMed
-
- Andrew MK, MacDonald S, Ye L, Ambrose A, Boivin G, Diaz-Mitoma F, Bowie W, Chit A, Dos Santos G, Elsherif M, et al. on behalf of CIRN SOS and TIBDN Network Investigators . Impact of frailty on influenza vaccine effectiveness and clinical outcomes: experience from the Canadian Immunization Research Network(CIRN) Serious Outcomes Surveillance (SOS) network 2011/12 season. Can Immunization Conf Abstract. 2016;3(suppl_1):s136. DOI: 10.1093/ofid/ofw172.573. - DOI
-
- Andrew MK, Lees C, Godin J, Black K, McElhaney J, Ambrose A, Boivin G, Bowie WR, Elsherif M, Green K, et al. Frailty hinders recovery from acute respiratory illness in older adults. Open Forum Infectious Diseases. 2017;4(suppl 1):S573–574. doi:org/10.1093/ofid/ofx163.1500.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous